298 related articles for article (PubMed ID: 25223726)
21. Solid-state characterization of buspirone hydrochloride polymorphs.
Sheikhzadeh M; Rohani S; Jutan A; Manifar T; Murthy K; Horne S
Pharm Res; 2006 May; 23(5):1043-50. PubMed ID: 16715396
[TBL] [Abstract][Full Text] [Related]
22. Exploring the solid-form landscape of pharmaceutical hydrates: transformation pathways of the sodium naproxen anhydrate-hydrate system.
Raijada D; Bond AD; Larsen FH; Cornett C; Qu H; Rantanen J
Pharm Res; 2013 Jan; 30(1):280-9. PubMed ID: 22996567
[TBL] [Abstract][Full Text] [Related]
23. Crystallization pathways and kinetics of carbamazepine-nicotinamide cocrystals from the amorphous state by in situ thermomicroscopy, spectroscopy, and calorimetry studies.
Seefeldt K; Miller J; Alvarez-Núñez F; Rodríguez-Hornedo N
J Pharm Sci; 2007 May; 96(5):1147-58. PubMed ID: 17455346
[TBL] [Abstract][Full Text] [Related]
24. Screening and Characterization of Hydrate Forms of T-3256336, a Novel Inhibitor of Apoptosis (IAP) Protein Antagonist.
Takeuchi S; Kojima T; Hashimoto K; Saito B; Sumi H; Ishikawa T; Ikeda Y
Chem Pharm Bull (Tokyo); 2015; 63(11):858-65. PubMed ID: 26521850
[TBL] [Abstract][Full Text] [Related]
25. Understanding the dehydration of levofloxacin hemihydrate.
Gorman EM; Samas B; Munson EJ
J Pharm Sci; 2012 Sep; 101(9):3319-30. PubMed ID: 22610517
[TBL] [Abstract][Full Text] [Related]
26. Preparation and characterization of a novel polymorph of indiplon, Form α.
Xu L; Wang J; Xiao B; Yang J; Liu Y; Huang R
Bioorg Med Chem Lett; 2012 Jan; 22(2):963-8. PubMed ID: 22209207
[TBL] [Abstract][Full Text] [Related]
27. Disproportionation of a crystalline citrate salt of a developmental pharmaceutical compound: characterization of the kinetics using pH monitoring and online Raman spectroscopy plus quantitation of the crystalline free base form in binary physical mixtures using FT-Raman, XRPD and DSC.
Skrdla PJ; Zhang D
J Pharm Biomed Anal; 2014 Mar; 90():186-91. PubMed ID: 24378612
[TBL] [Abstract][Full Text] [Related]
28. The solid-state characterization of fusidic acid.
Gilchrist SE; Letchford K; Burt HM
Int J Pharm; 2012 Jan; 422(1-2):245-53. PubMed ID: 22100514
[TBL] [Abstract][Full Text] [Related]
29. Physicochemical characterization of deflazacort: thermal analysis, crystallographic and spectroscopic study.
Cuffini SL; Ellena JF; Mascarenhas YP; Ayala AP; Sielser HW; Filho JM; Monti GA; Aiassa V; Sperandeo NR
Steroids; 2007 Mar; 72(3):261-9. PubMed ID: 17207826
[TBL] [Abstract][Full Text] [Related]
30. Diclofenac salts, part 7: are the pharmaceutical salts with aliphatic amines stable?
Fini A; Cavallari C; Bassini G; Ospitali F; Morigi R
J Pharm Sci; 2012 Sep; 101(9):3157-68. PubMed ID: 22234897
[TBL] [Abstract][Full Text] [Related]
31. The Stabilization of Amorphous Zopiclone in an Amorphous Solid Dispersion.
Milne M; Liebenberg W; Aucamp M
AAPS PharmSciTech; 2015 Oct; 16(5):1190-202. PubMed ID: 25732372
[TBL] [Abstract][Full Text] [Related]
32. Crystal structure and physicochemical properties of crystalline form of 2'-O-{3-[(7-chloro-4-quinolinyl)amino]propyl}-9-deoxo-9a-methyl-9a-aza-9a-homoerythromycin A.
Filić D; Starčević K; Pešić D; Jurmanović S; Meenan E; Spezzaferri A; Đilović I; Prugovečki B
J Pharm Sci; 2011 Jul; 100(7):2586-98. PubMed ID: 21394721
[TBL] [Abstract][Full Text] [Related]
33. A New Hydrate of Cyclosporine: Structural and Physicochemical Characterization.
Wu K; Gore A; Graham R
J Pharm Sci; 2018 Dec; 107(12):3070-3079. PubMed ID: 30114405
[TBL] [Abstract][Full Text] [Related]
34. Physical characterization of pantoprazole sodium hydrates.
Zupancic V; Ograjsek N; Kotar-Jordan B; Vrecer F
Int J Pharm; 2005 Mar; 291(1-2):59-68. PubMed ID: 15707732
[TBL] [Abstract][Full Text] [Related]
35. Physicochemical characterization of nedocromil bivalent metal salt hydrates. 1. Nedocromil magnesium.
Zhu H; Khankari RK; Padden BE; Munson EJ; Gleason WB; Grant DJ
J Pharm Sci; 1996 Oct; 85(10):1026-34. PubMed ID: 8897266
[TBL] [Abstract][Full Text] [Related]
36. Solid-state characterization and dissolution properties of Fluvastatin sodium salt hydrates.
Borgmann SH; Bernardi LS; Rauber GS; Oliveira PR; Campos CE; Monti G; Cuffini SL; Cardoso SG
Pharm Dev Technol; 2013; 18(2):525-34. PubMed ID: 23033850
[TBL] [Abstract][Full Text] [Related]
37. Application of 1-Dimensional and 2-Dimensional Solid-State Nuclear Magnetic Resonance Spectroscopy to the Characterization of Morphine, Morphine Hydrochloride, and Their Hydrates.
Romañuk CB; Garro-Linck Y; Alves de Santana MS; Manzo RH; Ayala AP; Monti GA; Chattah AK; Olivera ME
J Pharm Sci; 2017 Oct; 106(10):3033-3040. PubMed ID: 28551429
[TBL] [Abstract][Full Text] [Related]
38. Salt formation improved the properties of a candidate drug during early formulation development.
Sigfridsson K; Ahlqvist M; Lindsjö M; Paulsson S
Eur J Pharm Sci; 2018 Jul; 120():162-171. PubMed ID: 29730322
[TBL] [Abstract][Full Text] [Related]
39. Tris(hydroxymethyl) aminomethane salt of ramipril: synthesis, structural characterization from X-ray powder diffraction and stability studies.
Bhattacharya A; Chattopadhyay B; Chakraborty S; Roy BN; Singh GP; Godbole HM; Rananaware UB; Mukherjee AK
J Pharm Biomed Anal; 2012 Nov; 70():280-7. PubMed ID: 22877875
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of hydrate formation of a pharmaceutical solid by using diffuse reflectance infrared Fourier-transform spectroscopy.
Kojima T; Yamauchi Y; Onoue S; Tsuda Y
J Pharm Biomed Anal; 2008 Mar; 46(4):788-91. PubMed ID: 18191525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
